# What Does Unicycive Therapeutics, Inc.'s 39.1% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline

- Source: PR Newswire
- Published: 2026-10-22T18:40:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/what-does-unicycive-therapeutics-incs-39-1-stock-drop-mean-for-investors-the-law-offices-of-howard-g-smith-outlines-securities-fraud-class-action-lead-plaintiff-deadline-302916947.html
- Canonical: https://groundlevelnews.com/story/what-does-unicycive-therapeutics-inc-s-39-1-stock-drop-mean-for-invest-00ea7f/

Suit alleges Unicycive Therapeutics, Inc. failed to disclose key facts to investors from December 29, 2025 through June 29, 2026; lead plaintiff deadline is November 2, 2026 BENSALEM TOWNSHIP, Pa., Oct. 22, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith today reported that a...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._